Selection of diabetic patients for islet transplantation. A single-center experience

Diabetes and Metabolism

Volumn 30, Issue 5, 2004, Pages 417-423

  Vantyghem, M C ^a   Hazzan, M ^a   Tourvieille, S ^a   Provost, F ^a   Perimenis, P ^a   Declerck, N ^a   Sergent, G ^a   Kerr Conte, J ^a   Noel, C ^a   Pattou, F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Islet transplantation; Kidney transplantation; Type 1 diabetes

Indexed keywords

C PEPTIDE; GLUCOSE;

ADULT; ARTICLE; BODY WEIGHT; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; EXPERIENCE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SPECIALIST; MOTIVATION; PANCREAS ISLET CELL; PANCREAS TRANSPLANTATION; PATIENT; PATIENT REFERRAL; PATIENT SELECTION; PREGNANCY; PSYCHOLOGICAL ASPECT; PUMP; SCREENING; STIMULATION;

EID: 10644255722     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70137-4     Document Type: Article

References (20)

1. Shapiro AM, Ricordi C, Hering B. Edmonton's islet success has indeed been replicated elsewhere Lancet, 2003, 362, 9391.
2. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantatrion: continued insulin reserve provides long-term glycemic control Diabetes, 2002, 51, 2148-57.
3. Pattou F, Vantyghem MC, Noel C, et al. Sequential intraportal islet allografts in immunosuppressed type I diabetic patients: preliminary results. Transplant Proc, 2000, 32, 391-2.
4. Fioretto P, Folli F, Maffi P, et al. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation, 2003, 75, 1296-301.
5. Robertson RP. Islet transplantation as a treatment for diabetes-A work in progress. N Engl J Med, 2004, 350, 694-705.
6. Ryan EA, Shandro T, Paty B, Bigam D, Shapiro J, Vantyghem MC. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes, 2004, 53, 955-62.
7. Bohman SO, Tyden G, Wilczek H, et al. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes, 1985, 34, 306-8.
8. Fioretto P, Steffes MW, Sutherland D, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med, 1998, 339, 69-95.
9. Jukema JW, Smets YFC, Van der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care, 2002, 25, 906-11.
10. Gruessner AC, Sutherland DE. Analysis of United States and non-US pancreas transplantation reported to the United network for organ sharing at the international pancreas transplant registry as of October 2001. Clin Transpl, 2001, 41-72.
11. Bunnapradist S, Cho YW, Cecka, JM, Wilkinson A, Danovitch GM. Kidney allograft and patient survival in type 1 diabetic recipients of cadaveric kidney alone and simultaneous pancreas/kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol, 2003, 14, 208-13.
12. Lehmann R, Weber M, Zullig R, et al. Islet graft and kidney function in combined islet-kidney transplantation under a glucocorticoid free immunosuppressive regimen. 22nd workshop of the AIDSPIT study group, Igls 2003.
13. Vantyghem MC, Fajardy I, Pigny P, et al. Kinetics of diabetes-associated auto-antibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes. Diabetes Metab, 2003, 29, 1-7.
14. Halimi S, Zmirou D, Benhamou PY, et al. Progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart (Uremidiab 2 study). Diabetes Metab, 1999, 2, 507-12.
15. Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int, 2000, 58, 1742-50.
16. Benhamou PY, Marwah T, Balducci F, et al. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide. Clin Neprol, 1992, 38, 239-44.
17. Knoll GA, Nichol G. Dialysis, kidney transplantation, or pancreas transplantation for patients with diabetes mellitus and renal failure: a decision analysis of treatment options J Am Soc Nephrol, 2003, 14, 500-15.
18. Reddy KS, Stablein D, Taranto S, et al. Long term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure Am J Kidney Disease, 2003, 41, 464-70.
19. Venstrom JM, Mc Bride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function JAMA, 2003, 290, 2817-23.
20. Kessler L, Passemard R, Oberholzer J, et al. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplanlantation: interest of continuous glucose monitoring. Diabetes Care, 2002, 25, 2256-62.